Detalhe da pesquisa
1.
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
Cancer
; 129(7): 992-1004, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692409
2.
Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope.
Mycoses
; 66(1): 35-46, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36064299
3.
Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Br J Haematol
; 193(2): 271-279, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33403687
4.
Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy.
Hematol Oncol
; 37(4): 447-455, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31385337
5.
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax.
Am J Hematol
; 98(4): E80-E83, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36651870
6.
PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization.
Hematol Oncol
; 33(3): 125-32, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24890497
7.
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination-Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda.
Cancers (Basel)
; 16(2)2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38254875
8.
Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL).
Am J Hematol
; 93(2): E54-E57, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29164738
9.
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience.
Cancers (Basel)
; 15(13)2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37444567
10.
Validation of the "fitness criteria" for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL).
J Geriatr Oncol
; 12(4): 550-556, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097455
11.
Siltuximab and hematologic malignancies. A focus in non Hodgkin lymphoma.
Expert Opin Investig Drugs
; 26(3): 367-373, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28140696
12.
Novel agents in indolent lymphomas.
Ther Adv Hematol
; 4(2): 133-48, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23610620
13.
A new acute myeloid leukemia case with STAT5B-RARA gene fusion due to 17q21.2 interstitial deletion.
Leuk Lymphoma
; 58(8): 1977-1980, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27911132